Stocks News

LAST PRICE
58.6000
TODAY'S CHANGE (%)
Trending Up6.1200 (11.6616%)

Bid / Lots
58.1000/ 1
Ask / Lots
58.9000/ 2
Open / Previous Close
53.2000 / 52.4800
Day Range
Low 52.2100
High 59.9799
52 Week Range
Low 22.8900
High 79.4899
Volume
1,188,063
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 20, 2024
- Artificial Intelligence (AI) Reshaping Healthcare Industry with Unimaginable Potential, from 8:45AM ET on Wednesday Nov 20, 2024 by Dow Jones
  8:45AM ET on Wednesday Nov 20, 2024 by Dow Jones
  Companies Mentioned: MDT, AVAI, CLOV, TEM, TDOC
  
  New advancements in the AiBLE(TM) ecosystem build upon the company's commitment to procedural innovation and execution, and include the following: O-arm(TM) 4.3 software, which introduces advanced navigation volumes, dose reduction, and enhanced image confirmation. With this release, Medtronic now offers the industry's longest 3D scan length for cone-beam CT images, which allows surgeons to capture additional spine levels in one scan and streamline their workflow. O-arm(TM) is the first and only intraoperative imager that uses AI, with 70% less radiation dose compared to the standard protocol, while maintaining image quality. Medtronic Implant Resolution (MIR) further enhances decision-making by reducing metal artifacts around select screws, enabling confident final screw placement.
Nov 12, 2024
- DJ Tempus AI Price Target Raised to $70.00/Share From $40.00 by Piper Sandler, from 11:19AM ET on Tuesday Nov 12, 2024 by Dow Jones
  11:19AM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: TEM
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/TEM/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 12, 2024 11:19 ET (16:19 GMT)
- Tempus Molecular Profiling Integration Now Available Through Flatiron's OncoEMR(R), from 8:30AM ET on Tuesday Nov 12, 2024 by Dow Jones
  8:30AM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: TEM
  
  Tempus Molecular Profiling Integration Now Available Through Flatiron's OncoEMR(R)
  CHICAGO--(BUSINESS WIRE)--November 12, 2024--
  Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the collaboration with Flatiron Health, a leading healthtech company dedicated to expanding the possibilities of point of care solutions in oncology, to integrate its comprehensive genomic testing directly into Flatiron's cloud-based Electronic Medical Record (EMR) platform, OncoEMR(R) through the Molecular Profiling Integration (MPI). This integration will provide oncologists with seamless access to Tempus' suite of testing options, enhancing their ability to deliver personalized cancer care.
Nov 11, 2024
- Tempus Publishes Study Highlighting Benefits of Concurrent RNA and DNA Sequencing in Advanced Cancer Care, from 8:30AM ET on Monday Nov 11, 2024 by Dow Jones
  8:30AM ET on Monday Nov 11, 2024 by Dow Jones
  Companies Mentioned: TEM
  
  Tempus Publishes Study Highlighting Benefits of Concurrent RNA and DNA Sequencing in Advanced Cancer Care
  CHICAGO--(BUSINESS WIRE)--November 11, 2024--
  Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced publication of its study, "Actionable structural variant detection via RNA-NGS and DNA-NGS in patients with advanced non-small cell lung cancer, " in JAMA Network Open.
- Stifel Nicolaus Downgrades Tempus AI to Hold From Buy, Adjusts Price Target to $65 From $45, from 7:19AM ET on Monday Nov 11, 2024 by MT Newswires
  7:19AM ET on Monday Nov 11, 2024 by MT Newswires
  Companies Mentioned: TEM
  07:19 AM EST, 11/11/2024 (MT Newswires) -- Tempus AI (TEM) has an average rating of outperform and price targets ranging from $40 to $65, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research from m...

Today
- Blueprint Medicines Insider Sold Shares Worth $1,869,658, According to a Recent SEC Filing, from 47 minutes ago by MT Newswires
  47 minutes ago by MT Newswires
  Companies Mentioned: BPMC
- European Equities Traded in the US as American Depositary Rise in Friday Trading, Up Over 1% for Week, from 6 hours ago by MT Newswires
  6 hours ago by MT Newswires
  Companies Mentioned: ING, BBVA, TRIB, AMRN, OPRA, GNFT, AKTX, BNTX, AZN, SLN, TCBP, ASND, ADAP, SAN, BDRX, EDAP
Nov 19, 2024
- UBS Raises Price Target on Intra-Cellular Therapies to $87 From $79, Maintains Neutral Rating, from 10:56AM ET on Tuesday Nov 19, 2024 by MT Newswires
  10:56AM ET on Tuesday Nov 19, 2024 by MT Newswires
  Companies Mentioned: ITCI
- Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences, from 8:00AM ET on Tuesday Nov 19, 2024 by Dow Jones
  8:00AM ET on Tuesday Nov 19, 2024 by Dow Jones
  Companies Mentioned: ITCI
Nov 18, 2024
- DJ Blueprint Medicines Price Target Maintained With a $125.00/Share by JMP Securities, from 1:03PM ET on Monday Nov 18, 2024 by Dow Jones
  1:03PM ET on Monday Nov 18, 2024 by Dow Jones
  Companies Mentioned: BPMC
- European Equities Traded in the US as American Depositary Rise in Monday Trading, from 11:21AM ET on Monday Nov 18, 2024 by MT Newswires
  11:21AM ET on Monday Nov 18, 2024 by MT Newswires
  Companies Mentioned: NTZ, NVO, TEF, SQNS, GRFS, AMRN, OPRA, AKTX, MREO, SLN, EVAX, BP, TCBP, ASND, ADAP, BDRX
Nov 15, 2024
- DJ Ascendis Pharma Is Maintained at Buy by TD Cowen, from 1:48PM ET on Friday Nov 15, 2024 by Dow Jones
  1:48PM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: ASND
- DJ Ascendis Pharma Price Target Maintained With a $181.00/Share by Wedbush, from 1:11PM ET on Friday Nov 15, 2024 by Dow Jones
  1:11PM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: ASND
- European Equities Traded in the US as American Depositary Drop in Friday Trading, Down 2.8% for Week, from 11:09AM ET on Friday Nov 15, 2024 by MT Newswires
  11:09AM ET on Friday Nov 15, 2024 by MT Newswires
  Companies Mentioned: BBVA, LYG, PUK, ARGX, AKTX, MREO, BCYC, BNTX, EVAX, BTI, TCBP, DBVT, ASND, CLLS, SAN, BDRX
- DJ Ascendis Pharma Is Maintained at Outperform by Oppenheimer, from 11:03AM ET on Friday Nov 15, 2024 by Dow Jones
  11:03AM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: ASND

Tempus AI Inc
NASDAQ:TEMUnited States

Search Criteria

Nov 20, 2024

Artificial Intelligence (AI) Reshaping Healthcare Industry with Unimaginable Potential, from 8:45AM ET on Wednesday Nov 20, 2024 by Dow Jones

Nov 12, 2024

DJ Tempus AI Price Target Raised to $70.00/Share From $40.00 by Piper Sandler, from 11:19AM ET on Tuesday Nov 12, 2024 by Dow Jones

Tempus Molecular Profiling Integration Now Available Through Flatiron's OncoEMR(R), from 8:30AM ET on Tuesday Nov 12, 2024 by Dow Jones

Nov 11, 2024

Tempus Publishes Study Highlighting Benefits of Concurrent RNA and DNA Sequencing in Advanced Cancer Care, from 8:30AM ET on Monday Nov 11, 2024 by Dow Jones

Stifel Nicolaus Downgrades Tempus AI to Hold From Buy, Adjusts Price Target to $65 From $45, from 7:19AM ET on Monday Nov 11, 2024 by MT Newswires

Peers Headlines

Today

Blueprint Medicines Insider Sold Shares Worth $1,869,658, According to a Recent SEC Filing, from 47 minutes ago by MT Newswires

European Equities Traded in the US as American Depositary Rise in Friday Trading, Up Over 1% for Week, from 6 hours ago by MT Newswires

Nov 19, 2024

UBS Raises Price Target on Intra-Cellular Therapies to $87 From $79, Maintains Neutral Rating, from 10:56AM ET on Tuesday Nov 19, 2024 by MT Newswires

Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences, from 8:00AM ET on Tuesday Nov 19, 2024 by Dow Jones

Nov 18, 2024

DJ Blueprint Medicines Price Target Maintained With a $125.00/Share by JMP Securities, from 1:03PM ET on Monday Nov 18, 2024 by Dow Jones

European Equities Traded in the US as American Depositary Rise in Monday Trading, from 11:21AM ET on Monday Nov 18, 2024 by MT Newswires

Nov 15, 2024

DJ Ascendis Pharma Is Maintained at Buy by TD Cowen, from 1:48PM ET on Friday Nov 15, 2024 by Dow Jones

DJ Ascendis Pharma Price Target Maintained With a $181.00/Share by Wedbush, from 1:11PM ET on Friday Nov 15, 2024 by Dow Jones

European Equities Traded in the US as American Depositary Drop in Friday Trading, Down 2.8% for Week, from 11:09AM ET on Friday Nov 15, 2024 by MT Newswires

DJ Ascendis Pharma Is Maintained at Outperform by Oppenheimer, from 11:03AM ET on Friday Nov 15, 2024 by Dow Jones